Cohort Study of Intrauterine Diseases
Wenwen Wang
2,000 participants
Jul 1, 2025
OBSERVATIONAL
Conditions
Summary
"This study employs a prospective cohort design by establishing a uterine cavity diseases research platform. The investigators will collect participants' current medical history, menstrual and obstetric history, past medical history, physical and gynecological examinations, imaging studies, laboratory tests, and pathological examinations. After the hysteroscopic surgery, the investigators will conduct a one-year follow-up on the disease progression of the participants. Through this comprehensive approach, the investigators aim to deeply investigate the pathogenesis, risk factors, and optimized treatment strategies for uterine cavity diseases."
Eligibility
Inclusion Criteria4
- Age: 18-80 years;
- Patients requiring hysteroscopy or diagnostic curettage for intrauterine pathologies (e.g., endometrial hyperplasia, endometrial polyps, submucosal uterine fibroids, adenomyosis, or endometrial malignancies);
- Willing and able to comply with follow-up requirements;
- Signed informed consent obtained.
Exclusion Criteria4
- Concurrent participation in other drug clinical trials;
- Contraindications to or inability to tolerate hysteroscopy/curettage procedures;
- Unwilling or unable to provide informed consent;
- Unwilling or unable to adhere to study protocols.
Interventions
No intervention (observational study)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07048327